Table 21 Medication and agent groups for CKD with T2DM compared to [5]

n

Paper

1380

1122

144

159

258

32

16

UKW

10314

15315

34

4723

7656

1671

1601

Med1

6452

7009

*

2266

3319

734

765

Hypertension medication

Paper

76%

69%

63%

90%

92%

100%

97%

UKW

77%

68%

71%

89%

90%

89%

79%

Med1

85%

75%

*

96%

96%

96%

90%

Diuretics

Paper

36%

30%

22%

42%

58%

76%

34%

UKW

53%

39%

56%

60%

76%

82%

64%

Med1

63%

47%

*

65%

84%

90%

76%

Thiazide diuretics

Paper

24%

23%

18%

24%

30%

33%

0%

UKW

14%

13%

24%

22%

15%

10%

2%

Med1

12%

10%

*

23%

14%

7%

1%

Loop diuretics

Paper

14%

7%

3%

21%

31%

54%

34%

UKW

40%

26%

41%

40%

64%

78%

63%

Med1

51%

36%

*

43%

74%

88%

74%

Potassium-sparing diuretics

Paper

6%

6%

1%

4%

7%

8%

9%

UKW

11%

8%

6%

14%

20%

14%

6%

Med1

16%

11%

*

18%

27%

16%

9%

β-blockers

Paper

31%

24%

15%

45%

46%

76%

82%

UKW

52%

43%

38%

62%

66%

68%

58%

Med1

64%

52%

*

74%

77%

78%

71%

CC-Blocker

Paper

20%

15%

13%

37%

25%

33%

57%

UKW

29%

24%

29%

33%

35%

43%

37%

Med1

34%

28%

*

36%

39%

50%

45%

ACE inhibitors

Paper

40%

38%

43%

51%

42%

28%

41%

UKW

38%

35%

41%

50%

44%

34%

27%

Med1

43%

38%

*

56%

48%

37%

32%

ARB

Paper

22%

19%

11%

25%

32%

35%

16%

UKW

19%

16%

18%

24%

26%

25%

15%

Med1

24%

19%

*

30%

32%

32%

18%

RAAS

UKW

58%

52%

59%

74%

69%

59%

42%

Med1

68%

58%

*

86%

80%

68%

50%